Evoke Pharma Inc Services Agreements
10 Contracts & Agreements
- Manufacturing Services Agreement dated November 7, 2017, between the Company and Patheon UK Limited (Filed With SEC on March 14, 2024)
- Amendment No. 2 to the Commercial Services Agreement, dated as of November 3, 2022, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on November 9, 2022)
- Amendment No. 1 to the Commercial Services Agreement, dated as of February 1, 2022, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 10, 2022)
- 3PL Agreement between the Company and Eversana Life Science Services, Inc. dated August 27, 2020 (Filed With SEC on November 10, 2020)
- Commercial Services Agreement, dated as of January 21, 2020, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 12, 2020)
- First Amendment to the Commercial Services Agreement, dated as of February 28, 2019, between the Company and Novos Growth, LLC (Filed With SEC on May 8, 2019)
- Commercial Services Agreement, dated as of January 5, 2019, between the Company and Novos Growth, LLC.(certain portions of this exhibit have been omitted and are subject to... (Filed With SEC on May 8, 2019)
- Manufacturing Services Agreement dated November 7, 2017, between the Company and Patheon UK Limited (Filed With SEC on March 7, 2018)
- EVOKE PHARMA, INC. MASTER SERVICES AGREEMENT (Filed With SEC on August 14, 2017)
- THIRD AMENDMENT TO MASTER SERVICES AGREEMENT (Filed With SEC on March 25, 2014)
